Bilastine
RESPIRATORY SYSTEM
Also known as: bellozal, bilaxten, F-96221-BM1
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Bilastine is a drug catalogued in DrugCentral. DrugCentral lists 1 molecular target, including HRH1. Recorded indications include Allergic rhinitis and Urticaria.
- Molecular targets: HRH1 (1 listed in DrugCentral).
- Indications: Allergic rhinitis and Urticaria.
- ATC code: R06AX29 (Other antihistamines for systemic use).
- Molecular formula: C28H37N3O3; molecular weight 463.62 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (2)
- Allergic rhinitis
- Urticaria
Mechanism & targets
Molecular targets (1)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Histamine H1 receptor | HRH1 | antagonist | Ki 7.19 |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| — | PMDA | — | — |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
R06AX29 | RESPIRATORY SYSTEM › ANTIHISTAMINES FOR SYSTEMIC USE › ANTIHISTAMINES FOR SYSTEMIC USE › Other antihistamines for systemic use |
S01GX13 | SENSORY ORGANS › OPHTHALMOLOGICALS › DECONGESTANTS AND ANTIALLERGICS › Other antiallergics |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Urticaria | 692.8 |
| Pruritus | 302.3 |
| Angioedema | 278.1 |
| Chronic spontaneous urticaria | 182.7 |
| Erythema | 123.2 |
| Urticaria chronic | 116.8 |
| Skin plaque | 111.0 |
| Inappropriate schedule of product administration | 106.2 |
| Anaphylactic reaction | 94.3 |
| Urticarial vasculitis | 90.0 |
| Death | 85.5 |
| Asthma | 75.8 |
Chemical structure
| Molecular formula | C28H37N3O3 |
|---|---|
| Molecular weight | 463.62 g/mol |
| CAS number | — |
| InChIKey | ACCMWZWAEFYUGZ-UHFFFAOYSA-N |
| PubChem CID | 185460 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Bilastine used for?
DrugCentral lists the following indications for Bilastine: Allergic rhinitis and Urticaria.
How does Bilastine work?
Its molecular targets in DrugCentral include HRH1 (antagonist).
What is the chemical formula of Bilastine?
Bilastine has the molecular formula C28H37N3O3 and a molecular weight of 463.62 g/mol.
Browse: all drugs starting with B · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 4353 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1742423 — compound record and bioactivity
- PubChem CID 185460 — chemical identifiers
- DrugBank DB11591 — drug record
- FDA UNII PA1123N395 — substance identity
- UniProt P35367 (HRH1) — target protein
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.